Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1197447A discloses a robust method for resolving racemates like selegiline and ephedrine using stable phenoxypropionic acid derivatives, offering high purity and scalable manufacturing advantages.
Patent CN108777958B details a novel racemization method for 4-aminoindan derivatives, enabling cost reduction in agrochemical manufacturing by recycling inactive enantiomers.
Novel scalable route for L-penicillamine HCl via efficient racemization and resolution. Delivers high-purity pharmaceutical intermediates with optimized cost structures.
Novel resolution method for high-purity pharmaceutical intermediates. Cost-effective scale-up and supply chain reliability for kinase inhibitor synthesis.
Patent CN108779133A reveals a novel crystallization-induced dynamic resolution for Tenofovir Alafenamide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101104861B reveals a novel Yarrowia lipolytica lipase method for S-ibuprofen. Discover cost-effective, high-selectivity biocatalysis for pharmaceutical manufacturing.
Patent CN114014874B reveals a breakthrough recycling method for Baloxavir intermediates, offering significant cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN101701222B reveals a robust enzymatic route for (R)-mandelic acid, offering superior purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN101535467B discloses a novel biocatalytic route for chiral hydroxy acids using Fusarium proliferatum ECU2002, offering high optical purity and scalable manufacturing solutions.
High-purity S-tetrahydrofuranic acid via enzymatic resolution. Superior yield and optical purity for pharmaceutical intermediates supply chain.
Patent CN107098866A reveals cost-effective chemical resolution for Lesinurad enantiomers ensuring high purity and supply chain stability for pharmaceutical manufacturing partners globally.
Patent CN107098866A offers cost-effective chiral resolution for Lesinurad intermediates, ensuring high purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN103626668A offers high-efficiency resolution for S-pregabalin. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN102285961B details a cost-effective racemization method for duloxetine intermediates, enhancing yield and reducing environmental impact for pharmaceutical manufacturing.
Patent CN113480521B details a novel synthesis route for Bepotastine Besilate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners seeking scalable solutions.
Patent CN104745509B reveals a novel strain for producing optical pure agrochemical intermediates. Offers high ee value and scalable biocatalysis for cost reduction.
Patent CN106119224B reveals high-efficiency esterase for chiral synthesis. Offers mild conditions and supply chain stability for pharma intermediates.
Novel enzymatic process for high-purity D-tryptophan. Reduces cost and ensures supply continuity for pharmaceutical manufacturing.
Patent CN103074409A details a novel enzymatic resolution method for high-purity halogenated alpha-amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN116589475A enables high-purity HEX dye synthesis with reduced costs and improved supply chain reliability for biochemical labeling.